Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
Partner Content Partner Content M3 announces the acquisition of Vidal Group M3 is strengthening and growing its global operations
Views & Analysis From treatment to technology: a personal journey William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.
Views & Analysis Implementing cloud marketing technology Sanofi Pasteur MSD’s journey to digital has helped sales rep engagement, as well as compliant content creation and distribution.
Views & Analysis Artificial intelligence: the way ahead for pharma What has been its impact on the pharma and healthcare sectors?
Views & Analysis Blockchain protocol: applications in healthcare System promises improvements in clinical trial verification and anti-counterfeiting.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.